Evidence map›Paper›PMID 39713333›Full record

ArticlebioRxiv : the preprint server for biology2024

Gender-specific Single Transcript Level Atlas of Vasopressin and its Receptor (AVPR1a) in the Mouse Brain.

Anisa Gumerova, Georgii Pevnev, Funda Korkmaz, Uliana Cheliadinova, Guzel Burganova, Darya Vasilyeva, Liam Cullen, Orly Barak, Farhath Sultana, Weibin Zhou and 8 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Anisa GumerovaCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Georgii PevnevCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.ORCID 0000-0003-2015-9310
Funda KorkmazCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Uliana CheliadinovaCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Guzel BurganovaCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Darya VasilyevaCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Liam CullenCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Orly BarakCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Farhath SultanaCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Weibin ZhouCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.ORCID 0000-0002-9544-4266
Steven SimsCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.ORCID 0000-0002-1636-084X
Victoria LaurencinCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Tal FrolingerCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Se-Min KimCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Ki A GoosensCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.ORCID 0000-0002-5246-2261
Tony YuenCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Mone ZaidiCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.ORCID 0000-0001-5911-9522
Vitaly RyuCenter for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.ORCID 0000-0001-8068-4577

Funding

Targeting FSH for the Therapy of Osteoporosis, Obesity and NeurodegenerationU19AG060917 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Mone Zaidi · 2019 to 2026
$29.0M
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's DiseaseU01AG073148 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Tony Yuen, Mone Zaidi · 2021 to 2026
$10.6M
Elevated FSH - A Driver for Sex Differences in Alzheimer's DiseaseR01AG074092 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HAROUTUNIAN, VAHRAM, YUEN, TONY · 2021 to 2025
$6.3M
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly FemalesR01AG071870 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KIM, SE-MIN, YUEN, TONY · 2021 to 2025
$3.9M
Thyrotropin Receptor, Thyrotropin and Mechanisms of Bone LossR01DK113627 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DAVIES, TERRY FRANCIS, IQBAL, JAMEEL Z · 2017 to 2020
$2.8M
NIA NIH HHS R01 AG071870NIA NIH HHS R01 AG074092NIA NIH HHS U01 AG073148NIA NIH HHS U19 AG060917NIDDK NIH HHS R01 DK113627
6 · The paper itself

Abstract

Vasopressin (AVP), a nonapeptide synthesized predominantly by magnocellular hypothalamic neurons, is conveyed to the posterior pituitary

Identifiers

PMID39713333
PMCPMC11661174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.